Back to Journals » OncoTargets and Therapy » Volume 10

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]

Authors McCulloch D, Brown C, Iland H

Received 10 April 2017

Accepted for publication 10 April 2017

Published 8 May 2017 Volume 2017:10 Pages 2511—2512

DOI https://doi.org/10.2147/OTT.S139318

McCulloch D, Brown C, Iland H. Onco Targets Ther. 2017;10:1585–1601.

On page 1594, Table 3 contained several errors.

Read the original article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author: